Author

H. B. Sager

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Dutsch· 1 shared A. Friebe· 1 shared A. Kopczak· 1 shared A. Liesz· 1 shared C. Fürle· 1 shared C. Mauersberger· 1 shared D. Brough· 1 shared DEMDAS Study Group· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Dutsch

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Stroke induces early recurrent vascular events by inflammasome-dependent atherosclerotic plaque rupture

J. Cao, S. Roth, S. Zhang, A. Kopczak, M. K. Georgakis, X. Li, A. Dutsch, T. G. Liman, M. Endres, D. Brough, J. P. Green, S. R. Wernsdorf, C. Fürle, O. Carofiglio, J. Zhu, , A. Liesz

This study shows stroke triggers inflammasome-dependent atherosclerotic plaque rupture, leading to recurrent stroke, and identifies DNA-mediated inflammasome activation as a therapeutic target.

bioRxiv · Feb 1, 2023 · PreprintImmunology

Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation

C. Mauersberger, H. B. Sager, J. Wobst, T. A. Dang, L. Lambrecht, S. Koplev, M. Stroth, N. Bettaga, J. Schlossmann, F. Wunder, A. Friebe, J. L. Bjoerkegren, L. Dietz, P. Sandner, O. Soehnlein, , T. Kessler

This study shows that loss of soluble guanylyl cyclase in platelets promotes atherosclerosis by reducing angiopoietin-1 release and increasing leukocyte adhesion, suggesting sGC stimulation as a potential therapy for coronary artery disease.

bioRxiv · Nov 15, 2021Physiology